Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share (CARA)

CUSIP: 140755109

Q1 2021 13F Holders as of 31 Mar 2021

Holder snapshot 7 signals
Share change
-36,080
Put/Call ratio
21%
SEC-reported price per share
$21.71
Number of holders
156
Value change
+$3,235,940
Number of buys
70
Open additional details 1 more signal available
Number of sells
62
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
54,790,889

Security key

140755109

Report period

Q1 2021

Institutions

156

Top holders

10

Ownership snapshot

Top reported holders of CARA - Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BlackRock Finance, Inc.
Disclosed value leader
BlackRock Finance, Inc.
Comparable rows
15/15
Latest evidence
31 Dec 2020
13F Lead comparable stake: 6.6% Showing 1-6 of 15 holder rows.

Quick read

BlackRock Finance, Inc. leads the comparable SEC ownership view at 6.6%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BlackRock Finance, Inc.'s linked filing trail.
Comparable ownership Top 5
BlackRock Finance, Inc. 6.6%
FIRST MANHATTAN CO. LLC. 4.9%
FARALLON CAPITAL MANAGEMENT LLC 4.5%
PRICE T ROWE ASSOCIATES INC /MD/ 4.4%
VANGUARD GROUP INC 4.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BlackRock Finance, Inc.
13F
Company
13F
6.6%
$54,955,000
3,632,266 shares
31 Dec 2020
FIRST MANHATTAN CO. LLC.
13F
Company
13F
4.9%
$40,212,000
2,657,796 shares
31 Dec 2020
FARALLON CAPITAL MANAGEMENT LLC
13F
Company
13F
4.5%
$37,295,000
2,465,000 shares
31 Dec 2020
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
13F
4.4%
$36,754,000
2,429,235 shares
31 Dec 2020
VANGUARD GROUP INC
13F
Company
13F
4.1%
$34,176,000
2,258,763 shares
31 Dec 2020
Gestion Carmignac
13F
Individual
13F
3.4%
$28,012,000
1,851,443 shares
31 Dec 2020
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
156
Shares
29,844,915
Rows available
156
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders
146
Q1 2021 holders
156
Holder diff
10
Investor Q4 2020 Shares Q1 2021 Shares Share Diff Share Chg % Q4 2020 value Q1 2021 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .